The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Polycystic Ovary SyndromeVitamin D Deficiency
Interventions
DRUG

Vitamin D3

Women allocated to vitamin D arm received one capsule 50.000 IU of vitamin D3 once weekly for eight weeks.

OTHER

Placebo

Women in the placebo arm received once capsule of placebo once weekly for eight weeks

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER